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Unraveling the pathophysioiogy of IgE-mediated allergic disorders requires a 
thorough understanding of the complex mechanisms that control IgE antibody 
synthesis.  The selective activation and further maturation of the IgE B cell are 
regulated  by  both  antigen-specific  and  non-antigen-specific,  but  isotype-re- 
stricted, T  cells and the soluble factors that they produce (1-6). Although the 
manner by which antigen-specific and isotype-restricted regulatory events are 
coordinated is still unresolved, studies of Ishizaka and colleagues (7-13) and of 
our group (14-19) indicate that the Fc determinants of IgE and the correspond- 
ingly specific Fc receptors for IgE (FcR~)  ~  on lymphocytes contribute significantly 
to such regulatory mechanisms. 
IgE antibody responses can be significantly enhanced in experimental animals 
in which sensitization with antigen has been properly correlated with nonspecific 
perturbations such as low dose irradiation or treatment with immunosuppressive 
drugs (13, 20-23).  Similar perturbations, perhaps resulting from common res- 
piratory virus infections (15), could be responsible for development of high IgE 
responses in individuals exposed to allergens over a  sustained period of time 
(21), and are probably involved in the enhanced IgE production that accompanies 
parasite infections (22). Certain of the experimentally induced perturbations in 
normal mechanisms controlling IgE antibody responses can be  selectively re- 
versed by in vivo administration of biologically active soluble factors, obtained 
from body fluids of living animals (23). 
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The  experimental  manipulation  of a  given type of immune  response,  either 
by eliminating  the relevant B or T  cell components early in their development 
or  by  provoking  the  development  of negative  control  mechanisms  early  in 
ontogeny, has always yielded valuable information about the immune system (24, 
25). Recently, we have described a phenomenon in which neonatal treatment of 
mice with soluble or cell-bound monocional IgE molecules results in the devel- 
opment of profound IgE class-restricted immunodeficiency (26).  Such findings 
indicate that some cellular component(s) associated with the IgE antibody system, 
possibly capable of reacting specifically with ~ determinants  of IgE heavy chains 
(e.g.,  FcR~  + cells), are perturbed  when confronted by IgE at an  early stage of 
development;  this early perturbation  manifests itself in adulthood as persistent 
unresponsiveness in the IgE antibody class. 
In  the  present  report,  we  have  further  explored  the  IgE  class-restricted 
tolerance  model  in  order  to  develop  some  understanding  of the  mechanisms 
underlying defective IgE antibody synthesis in this system.  Herein, we demon- 
strate that (a) the IgE class-restricted tolerance-inducing  signal  is,  indeed, con- 
veyed by the Fc domain(s) of IgE  molecules; (b) the ability to develop isotype- 
restricted  tolerance  appears  to  be  unique  to  the  IgE  antibody  system,  since 
neonatal  treatment  with  other  immunoglobulin  (Ig) isotypes, which as IgA  or 
IgG, does not result  in corresponding isotype-restricted immunodeficiency; (c) 
spleen cells from IgE isotype-tolerant mice fail to express FcRE following stimu- 
lation in vitro with monoclonal IgE, a defect that distinguishes such tolerant mice 
from their normal control counterparts; and (d) neonatal treatment with soluble 
IgE generates  IgE class-specific suppressor T  ceils whose activity can be readily 
demonstrated  in  adoptive  transfer  experiments,  whereas  tolerance  induction 
with  cell-bound  IgE  appears  to  involve a  different  mechanism,  the  nature  of 
which is unresolved. 
Materials and Methods 
Reagents 
Proteins and  Chemicals.  The  following  materials  employed were  from  commercial 
sources:  2,4,6-trinitrobenzene  sulfonic  acid  (TNBS;  ICN  Pharmaceuticals,  Cleveland, 
OH); keyhole limpet  hemocyanin (KLH; Pacific Bio-Marine  Co.,  Venice,  CA); bovine 
serum albumin (BSA), ovalbumin (OVA), and dithiothreitol (DTT) (Sigma Chemical Co., 
St.  Louis,  MO);  CNBr-activated  Sepharose-4B  and  N-succinimidyl  3-(2-pyridyldithio) 
propionate (SPDP) (Pharmacia  Fine Chemicals,  Uppsala, Sweden). DNP28-BSA was pre- 
pared as previously described (27). 
Monoclonal and Conventional Antibody Reagents.  Monoclonal  anti-DNP antibodies of 
the IgE, IgG1, and IgG2b classes were obtained and purified from hybridomas constructed 
and characterized previously (27); that of the IgA class was from a myeloma line, MOPC 
315. The ragweed (RAG)-specific IgE monoclonal  antibody was obtained and purified as 
described recently (28). Rabbit anti-mouse  IgA  (RAMA)  was purchased  from  Litton 
Bionetics, Kensington,  MD. Other conventional antibodies were prepared in our labora- 
tory and  purified  by affinity  chromatography  on  specific immunoadsorbent  columns. 
These included  murine anti-KLH specific antibodies,  rabbit anti-mouse  IgG (RAMG), 
rabbit anti-mouse  IgE (RAME), goat anti-rabbit  immunoglobulin  (GARG), rabbit anti- 
KLH, and rabbit anti-BSA. 
Animals 
(BALB/c ×  SJL)Fj  mice  were  obtained  from  the  breeding  colonies  in  the animal 
quarters of the Medical Biology Institute.  Parental strains  of female  BALB/c and male CHEN ET AL,  955 
SJL mice were purchased from The Jackson Laboratory, Bar Harbor, ME. Adult male 
Lewis rats were obtained from Holtzman Co., Madison, WI. 
Covalent Conjugation of Monoclonal Antibodies to Splenocytes with the 
Heterobifunctional Reagent, SPDP 
The procedure was described in detail previously (26). Briefly, 50 #1 of freshly prepared 
solution (20 mM) of SPDP was added to 1 mi solution of DNP-specific monoclonal IgE, 
IgG1, IgG2b, or IgA (1  mg/ml) in phosphate-buffered saline, pH 7.5 (PBS).  The mixture 
was stirred gently for 30 min at room temperature (r.t.), then the excess SPDP reagent 
was removed by dialysis,  and the resulting 3-(2-pyridyldithio) propionyl protein derivative 
(PDP-protein) was recovered. To generate active sulfhydryl groups on the  splenocyte 
surface, 0.5 ml of 0.01  M DTT was added to 10 ml of 2% spleen cell suspension and the 
mixture was incubated at r.t. for  1 h. The DTT-treated cells were washed thoroughly 
with PBS, resuspended in  10 ml of PBS, and then reacted with PDP-proteins (1  mg/ml, 
10  mi)  at  r.t.  for  1  h.  Protein-coupled  splenocytes  were  washed  twice  in  PBS  and 
resuspended at appropriate concentrations  in  saline for injection.  The quantity of IgE 
molecules coupled to spleen cells was determined by radiolabeling tracer studies using 
125I-labeled PDP-IgE (26). 
Adoptive Transfer System 
The adoptive transfer system employed for IgE antibody responses was as described by 
Hamaoka et al. (29). Briefly, donor mice for KLH-immune spleen cells were prepared by 
immunizations with  1 #g KLH in  2 mg alum injected intraperitoneally (i.p.) at 2-3 wk 
intervals. In an adoptive transfer, 15 x  108 KLH-immune spleen cells together with 30 x 
106 spleen cells,  B cells,  or T  cells,  prepared from mice treated neonatally with IgE or 
control materials, were injected  intravenously to syngeneic recipients,  which had been 
irradiated  (650  rad)  in  a  ISTcesium irradiator on the same day.  Immediately after cell 
transfer, recipients were boosted with 1 #g KLH in 2 mg alum. Mice were bled 7 and 14 
d later, and their sera assayed for KLH-specific IgG and IgE antibodies. 
Assessment of  Antibody Responses 
Measurement ofAnti-KLH IgA Antibodies.  KLH-specific IgE antibody levels in pools of 
sera from each group were determined by passive cutaneous anaphylaxis (PCA) reactions, 
using male Holtzman rats as described in detail (29, 30). 
Measurement of  Anti-KLH IgG and lgA Antibodies.  KLH-specific IgG and IgA antibody 
levels in individual sera, were determined by a solid-phase radioimmunoassay (RIA) system 
in which serum samples were allowed to react with KLH on solid-phase, and then detected 
with either RAMG or RAMA, followed by 1~SI-labeled GARG as previously described in 
detail (26, 27).  For measuring IgA, DNP-specific MOPC 315 IgA myeioma proteins were 
used as standards. Geometric means and standard errors were obtained from at least four 
individual  mice in  each  group.  Statistical  differences were derived  by Student's  t  test 
between treated and control groups. 
Preparation of T Cell- and B Cell-enriched Lymphocyte Populations 
T  cell-enriched lymphocytes were prepared by the nylon wool method (31).  B cell- 
enriched lymphocytes were prepared by treating lymphocytes twice sequentially with anti- 
Thy-l.2 ascites (C3H anti-AKR) plus C as previously described (32). 
In Vitro System  for Induction  of FcRe  +  Lymphocytes 
The procedure  was  described  in  detail  (14).  Briefly,  l0  T splenic  lymphocytes from 
(BALB/c ×  SJL)F~ mice, neonatally treated with IgE or control materials, were cultured 
in  vitro  in  the  presence  of monoclonal antibodies at  varying final  concentrations  for 
various lengths of time. Triplicate cultures were pooled, washed twice, and resuspended 
7  +  at 5 ×  10  cells/ml. FcRe  lymphocytes were detected as cells that form rosettes with IgE- 
coated sheep erythrocytes (SRBC; reference 33) as described previously (14). 956  IgE CLASS-RESTRICTED TOLERANCE 
Results 
Induction  of IgE Class-restricted Tolerance by Neonatal Exposure of (BALB/c  x 
SJL) F~ Mice to Soluble Monoclonal IgE Antibodies of Two Distinct Antigen Specifici- 
ties.  (BALB/c  x  SJL)FI  mice were injected i.p.  with  various doses  of DNP- 
specific or RAG-specific monoclonal IgE antibodies from 0.25 #g to 250 ~g per 
injection on day 0 and day 6 after birth in 50 #I saline and in  100 #1 saline on 
day 13 and day 37. Control mice were treated with saline. At 3 months of age, 
these mice were immunized i.p. with 1 #g of KLH in 2 mg of alum and boosted 
likewise on day  10 and day 24  thereafter;  10  d  after the third immunization, 
sera were collected and analyzed for KLH-specific IgE and  IgG antibody re- 
spouses. 
Three points can be made from the results of this experiment, summarized in 
Fig.  1. First, as shown in A, IgE-restricted tolerance was induced with as little as 
2.5 #g of soluble IgE per injection; this dose is  100-fold less than the 250 #g of 
soluble IgE used in our first report (26). 
Second, the tolerance-inducing property resides in the constant region of the 
heavy chain. Thus, despite the fact that DNP-specific and RAG-specific mono- 
clonal IgE antibodies have very different antigen-binding specificities, they are 
equally effective in inducing IgE-restricted tolerance over a  3  log dose range. 
Third, this tolerance is restricted to the IgE antibody system, since KLH-specific 
IgG antibody responses were not significantly different between saline-treated 
or IgE-treated mice (B). 
IgE Class-restricted Tolerance Can Be Induced by Neonatal Exposure of (BALB/c 
x SJL)F1 Mice to Subnanogram Quantities of Syngeneic Cell-bound IgE.  Previously, 
IgE class-restricted tolerance was induced with 25-50 x  106 IgE-conjugated cells 
carrying 5-10  ng of monoclonal IgE per injection (26).  Since results in Fig.  1 
document that tolerance can be induced with considerably less soluble IgE than 
heretofore realized, the following experiment was conducted to determine the 
minimum quantity of cell-bound IgE required for tolerance induction. 
(BALB/c X SJL)FI mice were injected i.p. with various numbers, ranging from 
1 to 50 ×  106, of DNP-specific IgE-conjugated, or control untreated, syngeneic 
spleen cells on day 0 and day 10 after birth in 50 #1 saline and on day 17 in 100 
#1 saline. At 2 months of age, they were immunized i.p. with 1 #g of KLH in 2 
mg of alum and boosted on day  I0 and day 24 thereafter. Sera of these mice 
were collected on day 34,  i.e.,  10 d  after the third antigen immunization, and 
analyzed for KLH-specific IgE and IgG antibody responses. 
As  shown  in  Fig.  2,  all  three control  groups  developed both  IgE and  IgG 
antibody responses irrespective of whether they were sham-treated perinataily 
with  saline  (group  I)  or  with  two  different doses  of unconjugated syngeneic 
spleen cells (groups II and III).  In contrast, mice treated with IgE-conjugated 
cells  were  selectively unresponsive,  in  the  IgE  class,  even  at  the  lowest  cell 
number employed (1  x  106), which corresponds to an absolute amount of 0.2 ng 
of monoclonal IgE per injection. Thus, by comparison to the results presented 
in  Fig.  1,  where at  least  2.5  #g of soluble IgE per injection was required for 
induction of IgE class-restricted tolerance, cell-bound IgE is effective at a dose 
104 lower than the amount of soluble IgE needed to accomplish the same results. 
Isotype-restricted Tolerance by Neonatal  Exposure of (BALB/c  × SJL)FI Mice to CHENET AL. 
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FIGURE  1.  Induction of IgE class-restricted tolerance by neonatal exposure of (BALB/c X 
SJL)F1 mice to different doses of soluble monoclonal IgE of two distinct antigenic specificities. 
(BALB/c  ×  SJL)FI  mice  were  injected  i.p.  with  various  doses  of DNP-  or  RAG-specific 
monoclonal IgE in 50 #1 saline on day 0 and day 6 after birth and in 100 #1 saline on day 13 
and day 37. At 3 months of age, they were immunized i.p. with 1 #g of KLH in 2 mg of alum 
and boosted on day  10 and day 24 thereafter. Sera of these mice were collected on day 34 
and analyzed for IgE and  IgG anti-KLH antibody responses.  IgE antibody  responses  were 
determined from pooled sera in experimental groups consisting of 5-10 mice each. Individual 
IgG antibody responses were measured by RIA. Concentrations of IgG anti-KLH antibodies 
are expressed as geometric means 4- SE of the means of individual values from each group; 
no statistically significant differences exist among the groups. 958  lgE  CLASS-RESTRICTED TOLERANCE 
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FtGtJRE 2.  Induction of lgE class-restricted  tolerance by neonatal exposure of (BALB/c X 
SJL)F, mice to different doses of IgE-conjugated syngeneic cells. (BALB/c x SJL)F, mice were 
injected  i.p.  with  various  numbers of DNP-specific  IgE-conjugated syngeneic  spleen  cells, 
ranging from 1-50 x  108 cells, or control materials in 50 t~l saline on day 0 and day 10 after 
birth and in 100 ~1 saline on day 17. At 2 months of age, they were immunized i.p. with 1 ~g 
of KLH in 2 mg alum and boosted on day ] 0 and day 24 thereafter. Sera of these mice were 
collected on day 34 and analyzed for KLH-specific IgE and IgG antibody responses as described 
in Fig. 1. Each group consisted of at least 6 mice. Numbers in parentheses  depict actual PCA 
titers, where given. 
Monoclonal Antibodies Is Only Induced by IgE and Is Unique to the IgE Isotype.  The 
generality  of using a  monoclonal antibody of a  particular  class to induce class- 
restricted  unresponsiveness  of the corresponding isotype response was tested by 
administering  monoclonal  antibodies  of different  isotypes  to  neonates.  Thus, 
(BALB/c  x  SJL)F1  mice  were  injected  i.p.  with  either  saline  (controls)  or with 
monoclonal antibodies  of different classes, either  in soluble or cell-bound form, 
on  days  0,  12,  and  20  after  birth.  Only  the  highest  doses  of soluble  and  cell- 
bound IgE found to be effective in the previous experiments  were employed, to 
avoid negative  results  based  on threshold  dose  effects.  At  2  months  of age,  all 
mice were immunized  i.p.  with  1 ~g of KLH  in  2  mg of alum  and  boosted  on CHEN ET AL.  959 
day 10 and day 24 thereafter. Sera of these mice were collected on day 34 and 
analyzed for IgE, IgG, and IgA anti-KLH antibody responses. 
As shown in Fig. 3, both induction and subsequent expression of this isotype- 
specific tolerance are highly selective and specific for the IgE antibody system, 
and this type of isotype-specific tolerance does not operate in classes of antibody 
responses other than IgE under these conditions. Mice treated neonatally with 
soluble IgA,  IgG~,  IgG~h (groups  III-V),  or cell-bound IgA,  IgG~ plus IgG~ 
(groups  VII  and  VIII)  are  perfectly  capable  of producing antibodies  of the 
corresponding classes, i.e., antigen-specific IgA (right panel) and IgG (left panel) 
responses. Thus, mice treated with soluble IgA (group III) produce levels of IgA 
comparable  to  mice  treated  with  either  saline  (group  I)  or  other  types  of 
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FIGURE  3,  Isotype-restricted tolerance by neonatal exposure of (BALB/c x  SJL)F~  mice to 
monoclonal antibodies is only induced by IgE and is unique to the IgE isotype. (BALB/c x 
SJL)FI  mice  were  injected i.p.  with 250  ug of soluble monoclonal antibodies,  monoclonal 
antibodies coupled to syngeneic cells or control materials in 50/~1 saline on day 0 and day 12 
after birth and in 100/~1 saline on day 20. At 2 months of age, they were immunized i.p. with 
1 /~g of KLH  in 2  mg of alum and boosted on day  10 and day 24 thereafter. Sera of these 
mice were collected on day 34 and analyzed for IgE, IgG and IgA anti-KLH antibody responses. 
Each group consisted of ,5 to 8 mice. IgE antibody responses were determined from pooled 
sera in experimental groups. IgG and IgA antibody responses were measured by RIA and are 
expressed as geometric means __ SE of the means of individual values from each group. None 
of these latter values were significantly different among the groups. 960  lgE CLASS-RESTRICTED TOLERANCE 
immunogiobulins, i.e.,  IgE (group II), IgGl  (group IV), and IgG2b (group V). 
Likewise, mice treated with  IgA coupled to syngeneic cells, and those treated 
with  IgE and  IgG1  plus  IgG2b produce similar quantities of IgA (group VII). 
Furthermore, similar levels of IgG and IgE antibody responses are observed in 
groups treated with soluble or cell-bound IgA molecules. Similar observations 
were made  for  mice treated  neonatally with  soluble  IgGl  (group  IV),  IgGzb 
(group V), or cell-bound IgGl plus IgG~b (group VIII), since the total IgG as well 
as  IgA  and  lgE,  antibody responses  of these  mice are comparable  to  saline- 
treated control mice. 
The only class of monoclonal antibody that induces isotype-specific tolerance 
following neonatal administration is monoclonal IgE. Thus,  mice treated neo- 
natally  with  soluble  (group  II) or  cell-bound  (group  VI)  IgE are  completely 
tolerant with respect to their IgE antibody responses, whereas their IgA and IgG 
antibody  response  are  normal.  These  data  therefore suggest  that  a  constant 
region domain on IgE molecules uniquely conveys a  tolerogenic signal for the 
IgE antibody system. 
In Vitro Induction of  FcR~ + Cells Following Exposure to Monoclonal IgE Is Impaired 
in  Adult  Spleen  Cells  of Mice  Treated  Perinatally  with IgE  to  Induce  IgE  Class- 
restricted  Tolerance.  In  earlier studies  from  this  laboratory (14),  we  demon- 
strated  that  exposure  of normal  mouse  splenic  lymphocytes to  appropriate 
concentrations of monoclonal IgE in vitro resulted in the induction of significant 
numbers of cells expressing IgE-specific Fc  receptors, or FcR~.  Indeed, these 
observations,  together with  the  demonstrated ability  to  modulate such  FcR~ 
expression  by  concomitant  exposure  of the  same  cultures  to  the  IgE  class- 
restricted regulatory molecule, suppressive factor of allergy (SFA), prompted us 
to initiate the present series of experiments (26). Since the hypothesis leading to 
the design of such experiments was that  FcR~  + lymphocytes played important 
regulatory roles in  the IgE antibody system, it was thus pertinent to  examine 
whether mice treated perinatally with  IgE,  and rendered tolerant in  the IgE 
class-restricted fashion, displayed abnormal cellular behavior with regard to in 
vitro induction of FcR~ + lymphocytes by exposure to monoclonal IgE. 
To make this analysis, the ability of spleen cells from (BALB/c X SJL)FI mice 
treated perinatally with monoclonal IgE to respond to IgE by expression of FcR~ 
was compared to parallel control groups of F1 mice. Thus, spleens of mice from 
groups receiving the same materials three to four times from the experiments 
described in Figs.  1-3 were used as sources of spleen cells for these studies. All 
mice, either controls or those treated perinatally with soluble or cell-bound IgE, 
had been immunized with 1 #g KLH in alum three times at 10-14 day intervals, 
and were rested for approximately 3 months at the time their spleen cells were 
removed for the  FcR~  induction assay.  Single cell suspensions were prepared 
from a pool of three spleens for each group. 
Fig. 4 illustrates the kinetics of responses of such spleen cells to varying doses 
of IgE in vitro. Splenic lymphocytes (107/ml) from different groups of mice were 
cultured in the presence of different concentrations of monoclonai DNP-specific 
IgE for 24 h  and 48  h, and the frequency of de novo induced FcR~  ÷ cells was 
enumerated by their capacity to form rosettes with IgE-coated TNP-SRBC as 
indicator  cells.  As  shown  in  Fig.  4A,  spleen  cells from  control  mice  treated 25 
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EXPOSED TO DIFFERENT DOSES OF MONOCLONAL DNP-SPEClFIC IgE 
A.  INDUCTION-24 HOUF~ 
0  0.1  t  t0 
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CONCENTRATION  OF  MONOCLONAL DNP-SPECIFIC  ZgE  ADDED TO  CULTURE  (#g/ml) 
FIGURE 4.  Induction of FcR( + cells in culture of (BALB/c x  SjL)Ft spleen cells exposed to 
different doses of monoclonal DNP-specific IgE. (BALB/c x  SJL)FI hybrid mice were injected 
neonatally with IgE or control material in the experiments summarized in Figs.  1-3. These 
mice were pooled from groups of mice receiving the same materials 3  to 4  times from the 
aforementioned three separate experiments. All mice had been immunized with 1 ~¢g KLH in 
alum 3  times at  10-14-d intervals, and were rested for approximately three months.  Mice 
were about 6 months old at the time of assay. Single cell suspensions were made from spleens 
of 2-3 mice from each group.  107 splenic lymphocytes were cultured in RPMI with 5% FCS 
in the presence of different concentrations of monoclonal DNP-specific IgE for 24 h and 48 
h. The appearance of FcR~ + cells was enumerated by their capacity to form rosette with IgE- 
coated TNP-SRBC as indicator cells. 
neonatatly with saline gave rise to 26% FcR~  + cells upon stimulation with  10 #g/ 
ml of IgE in vitro for 24 h.  Likewise, spleen cells from mice treated neonatally 
with soluble IgA manifested clear induction of FcRe  + cells by doses of 1 and  10 
~g/ml of IgE.  In contrast, spleen cells from mice treated neonatally with 250 #g 
of soluble IgE of either  DNP or RAG specificities, or with  25-50  x  10  6  IgE- 
conjugated  spleen  cells were  significantly  impaired  in  their  ability  to  express 
FeRn. 
As shown in Fig. 4B, comparable results were obtained when these spleen cells 
were incubated for 48 h. When induced with 10 ug/ml of IgE, spleen cells from 
mice treated neonatally with IgE expressed only 5-7% of FcRe  + cells in contrast 
to  frequencies  of 22-28%  FcRe  +  cells  obtained  with  spleen  cells  from  mice 
treated with soluble IgA or saline. 
Neonatal Exposure of  (BALB/c X SJL)Fx Mice to Soluble lgE Induces Persistent IgE 
Class-restricted  Suppressor  T  Cells  Transferable  to  Irradiated  Adoptive  Recipi- 
ents.  The  preceding  experiment  documented  that  induction  of IgE  class-re- 
stricted  tolerance  is  accompanied  by an  inability  of cells  from  such  mice  to 
develop FcRe+ cells upon in vitro exposure to monoclonal IgE. The absence of 
such  inducible  cells could be the  direct  cause of unresponsiveness  in  the  IgE 
class,  or  this  could  be  a  secondary  manifestation  of some  other  mechanism 
underlying the unresponsive state. To ascertain whether suppressor cells may be 962  IgE CLASS-RESTRICTED TOLERANCE 
involved in the described IgE-restricted tolerance, the following experiment was 
undertaken. 
The protocol for this study is summarized on the left portion of Fig. 5, with 
the corresponding data from each part of the experiment depicted on the right 
portion of the same figure. As outlined in the top section of the figure, (BALB/ 
c × SJL)F~ mice were treated on days 0, 7, and 17 after birth with either control 
or experimental material. Control material consisted of either saline or 50 x  106 
unconjugated syngeneic spleen cells, while experimental material consisted of 
either soluble monoclonal IgE of two different specificities (anti-DNP and anti- 
RAG, 250 t~g per injection) or 50 ×  106 IgE-conjugated syngeneic spleen cells. 
At 2.5 months of age, they were immunized with 1 t~g of KLH in 2 mg of alum 
and boosted on day  10 and day 24  thereafter. Mice were rested for 52  d  and 
boosted with  1 t~g KLH in alum.  14  d  later, all groups were bled, killed, and 
their spleens removed to be used as one source of donor cells in the adoptive co- 
transfer experiment described below. The data summarized in the top portion 
of Fig. 5 verify that those donor mice treated with either soluble or cell-bound 
monoclonal  IgE  displayed  long-term  IgE  class-restricted  tolerance  that  had 
persisted over a period of six months after receiving only three treatments during 
the first 3 wk of life. 
The adoptive co-transfer experiment, which employed spleen cells from these 
tolerant mice and their corresponding controls,  is  summarized in  the bottom 
portion of Fig.  5.  The spleens from these donors were pooled by group and 
prepared as single cell suspensions.  Cells from donors treated neonatally with 
saline or with soluble DNP-specific monoclonai IgE were further fractionated on 
nylon wool columns to obtain a  T  cell-enriched fraction or treated with anti- 
Thy-l.2 plus C  to obtain the B ceil-enriched fraction. 30  ×  106 whole spleen 
cells, or T  cell-enriched or B cell-enriched fractions were then co-transferred 
intravenously with  15  ×  10  6  whole spleen  cells  from  KLH-hyperimmunized 
syngeneic donor mice into 650 rad irradiated syngeneic recipients. All recipients 
were challenged i.p. with  1 ~g of KLH in alum and bled 14 d later to assess the 
resulting IgE anti-KLH antibody responses. 
Whole spleen cells from donor mice tolerized by soluble IgE, when injected 
alone into  irradiated  recipients,  failed to develop IgE anti-KLH  antibody re- 
sponses upon antigen challenge (Table I, groups I-III). As shown in the bottom 
portion of Fig.  5,  co-transfer of spleen cells from donors treated with soluble 
DNP- or RAG-specific IgE suppressed the adoptive secondary IgE response of 
the KLH-hyperimmune donor cells, as contrasted to very good responses devel- 
oped by the same cells when co-transferred with spleen cells from control donors 
treated neonatally with saline (groups I-III). 
Spleen cells from donor mice treated neonatally with unconjugated syngeneic 
spleen cells developed good IgE anti-KLH antibody responses when they were 
adoptively transferred alone into  irradiated recipients, while donor cells from 
mice treated with IgE-conjugated cells failed to develop such responses (Table I, 
groups  IV and V).  However, as shown in  Fig.  5,  co-transfer of each of these 
donor  cell  types  with  KLH-hyperimmune spleen  cells  resulted  in  equivalent 
adoptive secondary IgE antibody responses (groups IV and V). 
When B cell- and T  cell-enriched fractions of spleens from donors treated CHEN  ET  AL.  963 
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TABLE I 
Spleen Cells  from (BALB/c × SJL) F~ Mice Rendered Tolerant by Neonatal Exposure to 
Soluble IgE or Cell-bound IgE Are Not Capable of Eliciting IgE Antibody Responses When 
Transferred into Irradiated Adoptive Recipients* 
30 × 106 Whole spleen cells from mice  KLH-Specific  lgE 
antibody response  Group  neonatally treated with:  (PCA titer) 
I  Saline  1,280 
II  IgE (DNP-specific)  <10 
Ill  IgE (RAG-specific)  <10 
IV  Unconjugated spleen  640 
V  IgE-Conjugated spleen cells (DNP-specific)  <10 
* (BALB/c x SJL) F~ mice were treated with monoclonal IgE or control material on days 0, 7, and 
17 after birth. At 2.5 months of age, they were immunized with 1 ~g of KLH in 2 mg of alum and 
boosted with I ~g KLH in alum. 14 d later, 30 x  106 whole spleen cells were injected into 650 rad 
irradiated syngeneic recipients and boosted with 1 t~g KLH in alum. 14 d later, mice were bled and 
the pooled sera were assessed for PCA responses. 
neonataily  with  either  saline  or  soluble  DNP-specific  IgE  were  examined  for 
suppressive  activities  in  this  co-transfer system,  neither  cell  type  from  saline- 
treated donors exerted any suppressive effects (groups VI and VII), and the T 
cell-enriched fraction actually caused a twofold enhancement of IgE responses. 
However, while the B cell-enriched fraction from the soluble IgE-treated donor 
spleen  exerted  no  detectable  effects on  the  adoptive  secondary  IgE  response 
(group  VIII),  the  T  cell-enriched  fraction  from  these  same  donor  spleens 
completely  abrogated  the  IgE  anti-KLH  secondary  responses  (group  IX).  It 
should  be  emphasized  that  all  of  the  suppressive  activities  observed  in  this 
experiment (groups II, III, and IX) were selective for responses of the IgE class, 
since  comparable  responses  among  all  groups  were  obtained  in  the  IgG  class 
(data not shown). 
Discussion 
The experiments presented herein further explored our previous observations 
on  the  phenomenon  of IgE class-restricted tolerance induced  by treatment  of 
neonatal mice with soluble or cell-bound IgE (26). The data obtained from these 
studies have established the following four points: 
Point  I.  IgE  class-restricted  tolerance  can  be  induced  in  this  system  by 
neonatal treatment  with monocional IgE,  irrespective of its antigen specificity, 
and the resulting effects appear to be polyclonal in nature since IgE responses 
specific  for  antigenic  determinants  unrelated  to  the  tolerance-inducing  IgE 
molecules are affected. Thus,  monocional IgE antibodies specific for the  DNP 
hapten,  on one hand,  and  for determinants of ragweed antigen,  on the other, 
were comparably effective in inducing this class-restricted tolerance. It is impor- 
tant that the ultimate IgE response tested in such mice as adults was directed to 
antigenic  determinants--in  this  case,  those  present  on  the  complex  protein, 
KLH--completely unrelated to the inducing IgE molecules. This formally elim- 
inates any possibility that our previous results (26), which employed only DNP- CHEN ET AL.  965 
specific monoclonal IgE,  could have reflected some unsuspected relationships 
between  the  DNP-haptenic  determinant with  dominant  determinants on  the 
KLH molecule, and supports the polyclonal nature of this tolerance phenome- 
non. Moreover, these findings strongly support the likelihood that the molecular 
subregion(s)  involved  in  inducing IgE  class-restricted tolerance in  the system 
resides in the Fc~ domain of the IgE molecule. 
Although not known at present, it will ultimately be important to determine 
the precise Fc~ molecular subregion(s) responsible for inducing this tolerance. 
Liu et al. (34) have cloned the cDNA specifying the ~ heavy chain fragment of 
the monoclonal DNP-specific IgE employed in these studies. This cloned cDNA 
contains the coding regions for part of the C~I and all of the C,2, C~3, and C,4 
domains of the  IgE  molecule.  Comparisons  with  human  IgE  reveal  that  ho- 
mologies of 36%, 47%, and 51% exist between mouse and human C~2, C~3, and 
C~4  domains,  respectively (34,  35).  Two  biological  observations suggest  that 
inductive signals conveyed by molecular regions in the FcE domains are highly 
conserved within the mouse and, possibly, between mouse and man: First, the 
murine DNP-specific IgE antibodies employed in these studies can induce expres- 
sion of FcR~ on lymphocytes derived from unrelated strains (C57BL/6 and SJL) 
of mice (Chen and Katz, unpublished observations). Second, in the aggregated 
form, this same monoclonal IgE has been shown to induce expression of FcRE 
on human lymphoid cells (36). Whether the conserved molecular subregions of 
Fce that induce expression of FcR~ on mouse and human lymphocytes, respec- 
tively, are the same as those responsible for inducing neonatal IgE class-restricted 
tolerance, in the system described herein, has yet to be determined. However, 
as will be discussed below, some suggestion of this derives from the finding that 
lymphoid cells from such tolerant mice are unresponsive to IgE-mediated FcRE 
expression. 
Point 2.  The induction of isotype-restricted tolerance by neonatal treatment 
with soluble or cell-bound immunoglobulin molecules appears  to be a  unique 
feature of the IgE antibody system. Thus, mice treated neonataily with soluble 
or ceil-bound IgA, IgG1, or IgG2b were perfectly capable of developing antibody 
responses of the IgA and IgG isotypes, respectively, when immunized as adults. 
This  contrasts  with  the  substantial  unresponsiveness,  in  the  IgE  class  only, 
manifested  by  mice  treated  neonatally  with  soluble  or  cell-bound  IgE.  The 
reasons for such differences are unknown, but do not necessarily infer something 
physiologically unique about  the  IgE  system.  Rather,  since the  IgE system is 
programmed to produce considerably lesser amounts of IgE antibody molecules 
than is true of other immunoglobulin isotypes, the system may be considerably 
more sensitive to perturbations conveyed by neonatal treatment in the manner 
employed in this system. 
Point 3.  Lymphoid cells obtained from mice treated neonatally with IgE, and 
subsequently manifesting IgE class-restricted tolerance, do not develop FcR~ + 
cells upon in  vitro stimulation with  IgE, as is characteristic of their untreated 
counterparts. This failure of such cells to express FcR~ probably involves both B 
and T  cells, since we have previously shown that in  vitro induction with  IgE 
(using normal mouse spleen cells) results in equivalent numbers of FcR~  + B and 
T  cells (14). Since recent studies in our laboratory have demonstrated that IgE- 966  lgE CLASS-RESTRICTED TOLERANCE 
mediated in vitro induction of FcRe  + lymphocytes reflects a  cascade of events 
beginning with B lymphocytes and then subsequently proceeding to T  lympho- 
cytes (15-19),  this unresponsiveness to FcRe expression could only be at the B 
cell level in order to yield the results observed herein; however, it is not possible 
to  determine whether such  treatment affects only  B  cells  or  both  B  and  T 
lymphocytes capable  of expressing  FcRe.  In  any case,  the  failure of tolerant 
spleen cells to express FcRe following in vitro induction of IgE could reflect one 
or more of the following events: first, exposure of immature FcRe+ cells to IgE 
during the neonatal period could result in irreversible negative modulation of 
such Fc receptors. Alternatively, such exposure could render such FcR~  + cells 
residually capable of expressing FcR,, but only at a low density that would then 
be  insensitive  to  detection  by  the  rosette  assay  employed.  Second,  neonatal 
exposure to IgE could induce suppressive regulatory cells which, when subse- 
quently exposed to IgE,  might prevent the development of FcRE÷ cells in this 
system. This is reminiscent of earlier observations reported by us demonstrating 
that the IgE-selective regulatory factor, suppressive factor of allergy (SFA) quite 
effectively inhibits IgE-mediated FcRe expression in vitro (14, 16,  19, 37). 
Although it is not possible at this time to draw conclusions about the relation- 
ship between lack of inducible FcRe+ cells and the IgE isotype-restricted tolerance 
phenomenon, we believe that the corollary observations are important and very 
likely related to one another. Considerable evidence has been recently accumu- 
lated  indicating that  FcR  ÷ cells participate  significantly in  regulating isotype- 
specific antibody responses. Suppressor T  cells and their released soluble prod- 
ucts, some of which are immunoglobulin-binding factors (IBF), that selectively 
inhibit synthesis of IgG~,  IgG~a, and IgG2b  have been demonstrated by other 
investigators (38, 39). Similarly, in the IgA system FcRo~  + T  cells generated in 
high quantities in IgA myeloma-bearing mice, have been shown to regulate the 
synthesis of IgA (40). In the IgE system, FcRe  ÷ cells, and their secreted soluble 
products, have been shown to positively or negatively regulate various aspects of 
the IgE antibody system (7-19, 37). 
Interestingly, the experimental system described herein reveals an insensitivity, 
relative to that observed with IgE, to neonatal perturbation by administration of 
IgA,  IgG1,  or  IgG2b. As  mentioned above,  this  could  reflect the  substantial 
differences in magnitudes of IgE immunoglobulin levels produced in the normal 
situation as contrasted to quantities of other immunogiobulin isotypes. 
Point  4.  Mice  rendered  tolerant  by  neonatal  treatment  with  soluble  IgE 
possess IgE class-restricted suppressor T cells as a result of the neonatal treatment 
regimen; no detectable suppressor T  cells were observed in mice treated with 
cell-bound IgE. This may indicate that two different mechanisms underlie the 
IgE class-restricted tolerance observed in this model. One possible explanation 
is that IgE-specific helper T  cells are somehow affected in mice treated with cell- 
bound IgE since (a) such mice do not respond to antigen challenge in situ, and 
(b)  their  cells remain  unresponsive when adoptively-transferred to  irradiated 
syngeneic recipients (Table I). Although IgE class-specific suppressor cells cannot 
be demonstrated by co-adoptive celt transfer techniques (Fig.  5),  it is possible 
that cell-bound IgE may be able to elicit suppressor T  cells which, together with CHEN ET AL.  967 
suppressive  factors  that  they may produce,  could  maintain  the  unresponsive 
phenotype in situ. 
On the other hand, mice treated neonatally with soluble IgE are unresponsive 
to in  situ antigen challenge, but also possess  IgE class-restricted suppressor T 
cells demonstrable in adoptive transfer circumstances. It is possible that neonatal 
treatment with soluble IgE more effectively generates transferable suppressor T 
cells as a  result of an interaction between fluid-phase IgE and FcR~  + precursor 
cells resulting in an IgE-FcR~  + cell surface complex which, in turn, may induce 
second-order suppressive regulatory cells. Since FcR~  + cells cannot be induced 
in lymphoid populations  from such tolerant mice, we favor the interpretation 
that these second-order suppressor cells, once induced, may be maintained in 
such animals and actively suppress  the development of IgE antibody-forming 
cells and/or IgE Class-specific  helper T  cells via receptors directed against the 
FcR~ itself. 
This experimental system of IgE isotype-restricted tolerance provides a differ- 
ent avenue  for  exploring  the  composition  and  complex  cellular  interactions 
regulating the IgE antibody system. Delineating the precise tolerance-inducing 
molecular sites on the IgE molecule and the mechanism by which tolerogenic 
signals are delivered could  ultimately help  to  unravel  molecular mechanisms 
controlling IgE antibody synthesis and, perhaps, synthesis of other immunoglob- 
ulin isotypes as well. 
Summary 
Certain aspects of the phenomenon of IgE class-restricted tolerance induced 
in mice by neonatal treatment with monoclonal IgE, either in soluble form or 
coupled to syngeneic spleen cells, were examined. The present studies document 
that this tolerance results from exposure to IgE molecules, irrespective of their 
antigen specificity, and the resulting effects are polyclonal in nature since IgE 
responses directed against antigenic determinants unrelated to  the tolerance- 
inducing IgE molecules are affected. Moreover, such findings indicate that the 
molecular subregion(s)  responsible  for  inducing  IgE class-restricted tolerance 
resides in the e heavy chain constant region domain(s) of IgE. When soluble IgE 
is employed, tolerance induction results from neonatal treatment with doses as 
low as  2.5  #g  per  injection  per  mouse;  ceil-bound IgE  is  considerably more 
potent, in terms of total dose required,  since tolerance results from treatment 
with as few as 1 ×  10  6 cells per injection (per mouse), equivalent to an absolute 
quantity of 0.2  ng of IgE per injection. This long-term class-specific tolerance 
appears to be a  unique feature of the IgE antibody system, since treatment of 
mice with monoclonal antibodies of the IgA, IgGl, or IgG2b istoypes, either in 
soluble or cell-bound form, does not perturb antibody responses of their corre- 
sponding isotypes or in the IgE class. 
By  analyzing  the  lymphoid  cells  of  IgE-tolerant  mice  after  they  reached 
adulthood, the following observations were made: (a) lymphoid cells from such 
tolerant mice fail to develop FcR~ ÷ cells upon in vitro stimulation with IgE, as is 
characteristically observed with lymphoid cells from nontolerant mice; and (b) 
mice rendered tolerant by neonatal treatment with soluble IgE possess IgE class- 
restricted suppressor  T  cells,  demonstrable in  adoptive  transfer experiments, 968  IgE  CLASS-RESTRICTED TOLERANCE 
whereas  no such  suppressor cells are evident in  mice in  which  ceil-bound  IgE 
was used for neonatal  treatment.  The latter observations could mean that two 
different mechanisms underlie the IgE class-restricted tolerance, or both mech- 
anisms operate coordinately to varying degrees depending upon which regimen 
is used for tolerance induction, as discussed herein. 
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